• News
  • SAN DIEGO
  • Medical

Illumina links with big pharmas on cancer research

San Diego’s Illumina Inc. (Nasdaq: ILMN) announced Thursday that it has formed collaborative partnerships with three leading pharmaceutical companies to develop a universal next-generation genetic sequencing test system for cancers.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
198.46
  2.24  
+ 1.14%
714,201,000
213.33
127.69

Insider Trade Data

Date Insider Shares Type Value
02/17/2015 Walt, David R 7,000 Sell $1,386,125
02/12/2015 Flatley, Jay T 25,000 Sell $4,865,990
02/12/2015 Flatley, Jay T 25,000 Exchange $569,775
02/12/2015 Flatley, Jay T 25,000 Sell $4,865,990
02/12/2015 Flatley, Jay T 25,000 Exchange $569,775

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
SIC - 3826 - LABORATORY ANALYTICAL INSTRUMENTS
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!